ATE263166T1 - Neue benzoxazole mit pde-hemmender wirkung - Google Patents

Neue benzoxazole mit pde-hemmender wirkung

Info

Publication number
ATE263166T1
ATE263166T1 AT99931198T AT99931198T ATE263166T1 AT E263166 T1 ATE263166 T1 AT E263166T1 AT 99931198 T AT99931198 T AT 99931198T AT 99931198 T AT99931198 T AT 99931198T AT E263166 T1 ATE263166 T1 AT E263166T1
Authority
AT
Austria
Prior art keywords
pde
inhibiting effect
benzoxazoles
new
new benzoxazoles
Prior art date
Application number
AT99931198T
Other languages
German (de)
English (en)
Inventor
Wolf-Ruediger Ulrich
Hermann Amschler
Thomas Baer
Dieter Flockerzi
Beate Schmidt
Ulrich Thibaut
Armin Hatzelmann
Hildegard Boss
Rolf Beume
Hans-Peter Kley
Dietrich Haefner
Thomas Martin
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of ATE263166T1 publication Critical patent/ATE263166T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT99931198T 1998-07-06 1999-06-26 Neue benzoxazole mit pde-hemmender wirkung ATE263166T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98112469 1998-07-06
PCT/EP1999/004451 WO2000001695A1 (en) 1998-07-06 1999-06-26 New benzoxazoles with pde-inhibiting activity

Publications (1)

Publication Number Publication Date
ATE263166T1 true ATE263166T1 (de) 2004-04-15

Family

ID=8232222

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99931198T ATE263166T1 (de) 1998-07-06 1999-06-26 Neue benzoxazole mit pde-hemmender wirkung

Country Status (14)

Country Link
US (1) US6376485B1 (enExample)
EP (1) EP1095040B1 (enExample)
JP (1) JP2002519423A (enExample)
AT (1) ATE263166T1 (enExample)
AU (1) AU761647B2 (enExample)
CA (1) CA2336894A1 (enExample)
DE (1) DE69916066T2 (enExample)
DK (1) DK1095040T3 (enExample)
ES (1) ES2219031T3 (enExample)
IL (1) IL140468A0 (enExample)
PT (1) PT1095040E (enExample)
SI (1) SI1095040T1 (enExample)
WO (1) WO2000001695A1 (enExample)
ZA (1) ZA200100088B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83620C2 (ru) 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
CA2625153A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
JP2010502722A (ja) 2006-09-08 2010-01-28 ブレインセルス,インコーポレイティド 4−アシルアミノピリジン誘導体を含む組み合わせ
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP2225215A1 (en) * 2007-11-21 2010-09-08 Decode Genetics EHF Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405633A (en) * 1982-03-01 1983-09-20 Usv Pharmaceutical Corporation Method of treatment of asthma
US4490373A (en) * 1983-05-20 1984-12-25 Usv Pharmaceutical Corporation Method of treating asthma
KR100237962B1 (ko) * 1994-10-12 2000-02-01 그린 마틴 신규한 벤즈옥사졸
DE59610031D1 (de) * 1995-05-18 2003-02-06 Altana Pharma Ag Cyclohexyldihydrobenzofurane
WO1996036624A1 (en) * 1995-05-19 1996-11-21 Kyowa Hakko Kogyo Co., Ltd. Oxygen-containing heterocyclic compounds

Also Published As

Publication number Publication date
IL140468A0 (en) 2002-02-10
DK1095040T3 (da) 2004-07-26
SI1095040T1 (en) 2004-10-31
ZA200100088B (en) 2002-05-06
WO2000001695A1 (en) 2000-01-13
CA2336894A1 (en) 2000-01-13
ES2219031T3 (es) 2004-11-16
PT1095040E (pt) 2004-08-31
AU761647B2 (en) 2003-06-05
DE69916066D1 (de) 2004-05-06
DE69916066T2 (de) 2005-02-24
JP2002519423A (ja) 2002-07-02
AU4778699A (en) 2000-01-24
US6376485B1 (en) 2002-04-23
EP1095040A1 (en) 2001-05-02
EP1095040B1 (en) 2004-03-31

Similar Documents

Publication Publication Date Title
ATE402174T1 (de) Imidazopyridinderivate als kinaseinhibitoren
ECSP066314A (es) Derivados piridilo y su uso como agentes terapéuticos
EA200501009A1 (ru) Замещённые пирролопиразольные производные в качестве ингибиторов киназы
CY1116103T1 (el) Υποκατεστημενα παραγωγα 1,2,3,4-τετραϋδροϊσοκινολινης
CY1110332T1 (el) Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους
BR0113643A (pt) Compostos de guanidinobenzamidas como agonistas de mc4-r e seus usos
CY1108339T1 (el) Παραγωγα spiro(2h-1-benzopyran-2,4´-piperidine) ως αναστολεις της μεταφορας γλυκινης
MA27040A1 (fr) Nucleosides substitues en 4'
ATE537830T1 (de) Nicotinamid derivate und ihre verwendung als therapeutika
NO20060664L (no) N-substituerte benzimidazolyl C-kit inhibitorer
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
DE60140456D1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
ATE327977T1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
CR6577A (es) Inhibidores triciclicos de poli(adp-ribosa) polimerasas
NZ527249A (en) Purine derivatives as purinergic receptor antagonists
ATE263166T1 (de) Neue benzoxazole mit pde-hemmender wirkung
DK1412354T3 (da) Derivater af triazolylimidazopyridin og af triazolylpurinerne, der er egnede som ligander for adenosin A2a?-receptoren og deres anvendelse som medikamenter
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
DK0992509T3 (da) Nye makrolid-derivater
SE0301699D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
EP2266566A3 (en) Nicotinamide derivatives and their use as therapeutic agents
NO20053876D0 (no) Karbonylaminosubstituerte acylfenylurederivater, fremgangsmate for deres fremstilling samt anvendelse derav

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1095040

Country of ref document: EP

REN Ceased due to non-payment of the annual fee